Skip to main content
Equibles
LUNG logo

LUNG · Pulmonx Corp

Track LUNG — free

Use LUNG with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about LUNG

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$2.42 +0.26 (+12.04%) At close · Aug 14
Market Cap
$103.93M
Shares
42.95M

Pulmonx Corp Earnings Call Transcripts

Every quarterly earnings call for Pulmonx Corp (LUNG) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲1.8% $13.50M −$14.17M '22 Q3 22-11-03 ▲12.5% $15.43M −$14.28M '22 Q4 23-02-22 ▲34.8% $14.54M −$15.86M '23 Q1 23-05-02 ▲23.3% $17.19M −$16.20M '23 Q2 23-08-02 ▲30.9% $17.67M −$14.90M '23 Q3 23-10-10 ▲25% $19.28M −$13.89M '23 Q4 24-02-21 ▲29.7% $18.85M −$13.75M '24 Q1 24-05-01 ▲20.9% $20.78M −$15.33M '24 Q2 24-07-31 ▲15.4% $20.39M −$14.14M '24 Q3 24-10-30 ▲23.3% $23.77M −$13.18M '24 Q4 25-02-19 ▲19.5% $22.54M −$14.45M '25 Q1 25-04-30 ▲14.8% $23.86M −$15.17M '25 Q2 25-07-30 ▲5.5% $21.50M −$13.96M '25 Q3 25-10-27 ▼4.9% $22.60M −$10.43M '25 Q4 26-03-04 ▼8.7% $20.59M −$13.65M '26 Q1 26-04-29 LATEST ▼4.6% $22.76M −$10.08M '26 Q2 26-07-29
Conference
Investor event
2026-08-11
Canaccord Genuity 46th Annual Growth Conference
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q2
2026-07-29
Pulmonx Q2 2026 Earnings Conference Call
Revenue
$22.76M
▼ 4.6% YoY
Diluted EPS
$-0.24
Gross margin
78.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-04-29
Pulmonx Corp Q1 FY2026 Earnings Call
Positive tone China distributor / registration Guidance and outlook Clinical pipeline / market expansion
Revenue
$20.59M
▼ 8.7% YoY
Diluted EPS
$-0.33
Gross margin
77.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-03-04
Pulmonx Q4 2025 Earnings Conference Call
Balanced tone U.S. Sales Reacceleration Clinical Initiatives and Market Expansion Cost Realignment and Profitability
Revenue
$22.60M*
▼ 4.9% YoY
Gross margin
77.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-10-27
Pulmonx Corp Q3 FY2025 Earnings Call
Cautious tone Slowing U.S. growth and commercial execution Path to profitability and strategic refocus Q3 2025 financial results
Revenue
$21.50M
▲ 5.5% YoY
Diluted EPS
$-0.34
Gross margin
74.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-07-30
Pulmonx Corp Q2 FY2025 Earnings Call
Cautious tone Capacity and Lung Cancer Screening Tailwinds International / OUS Growth LungTrax Detect AI Screening Tool
Revenue
$23.86M
▲ 14.8% YoY
Diluted EPS
$-0.38
Gross margin
72.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-04-30
Pulmonx Corp Q1 FY2025 Earnings Call
Positive tone Acquired test and treat commercial strategy Physician and patient education Revenue performance and full-year guidance
Revenue
$22.54M
▲ 19.5% YoY
Diluted EPS
$-0.36
Gross margin
72.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-19
Pulmonx Corp Q4 FY2024 Earnings Call
Confident tone Acquire, Test, Treat Strategy International Expansion Revenue Growth and Guidance
Revenue
$23.77M*
▲ 23.3% YoY
Gross margin
74.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-10-30
Pulmonx Corp Q3 FY2024 Earnings Call
Positive tone Zephyr Valve Commercial Expansion Revenue Growth and Guidance Physician and Patient Awareness
Revenue
$20.39M
▲ 15.4% YoY
Diluted EPS
$-0.36
Gross margin
73.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-07-31
Pulmonx Corp Q2 FY2024 Earnings Call
Confident tone International / European Seasonality US Commercial Growth & Account Expansion Full-Year 2024 Revenue Guidance
Revenue
$20.78M
▲ 20.9% YoY
Diluted EPS
$-0.39
Gross margin
73.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-01
Pulmonx Corp Q1 FY2024 Earnings Call
Confident tone Zephyr Valve Market Opportunity Operating Expense and Leverage AeriSeal Pipeline Expansion
Revenue
$18.85M
▲ 29.7% YoY
Diluted EPS
$-0.36
Gross margin
74.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-21
Pulmonx Corp Q4 FY2023 Earnings Call
Confident tone AeriSeal / CONVERT clinical development International and Japan market expansion Zephyr Valve commercial growth and account expansion
Revenue
$19.28M*
▲ 25% YoY
Gross margin
74.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-10-10
Pulmonx Corp Q3 FY2023 Earnings Call
Revenue
$17.67M
▲ 30.9% YoY
Diluted EPS
$-0.39
Gross margin
73.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-02
Pulmonx Corp Q2 FY2023 Earnings Call
Revenue
$17.19M
▲ 23.3% YoY
Diluted EPS
$-0.43
Gross margin
74.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-02
Pulmonx Corp Q1 FY2023 Earnings Call
Revenue
$14.54M
▲ 34.8% YoY
Diluted EPS
$-0.42
Gross margin
72.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-22
Pulmonx Corp Q4 FY2022 Earnings Call
Revenue
$15.43M*
▲ 12.5% YoY
Gross margin
72.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-03
Pulmonx Corp Q3 FY2022 Earnings Call
Revenue
$13.50M
▲ 1.8% YoY
Diluted EPS
$-0.38
Gross margin
75.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-02
Pulmonx Corp Q2 FY2022 Earnings Call
Revenue
$13.95M
▲ 14.3% YoY
Diluted EPS
$-0.40
Gross margin
74.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-03
Pulmonx Corp Q1 FY2022 Earnings Call
Revenue
$10.79M
▲ 16.7% YoY
Diluted EPS
$-0.43
Gross margin
75.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-23
Pulmonx Corp Q4 FY2021 Earnings Call
Revenue
$13.71M*
▲ 39.5% YoY
Gross margin
74.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-02
Pulmonx Corp Q3 FY2021 Earnings Call
Revenue
$13.26M
▲ 25% YoY
Diluted EPS
$-0.28
Gross margin
73.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-03
Pulmonx Corp Q2 FY2021 Earnings Call
Revenue
$12.20M
▲ 232.2% YoY
Diluted EPS
$-0.36
Gross margin
74.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-04
Pulmonx Corp Q1 FY2021 Earnings Call
Revenue
$9.24M
▲ 7.3% YoY
Diluted EPS
$-0.35
Gross margin
71.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-03-02
Pulmonx Corp Q4 FY2020 Earnings Call
Revenue
$9.83M
▼ 5% YoY
Gross margin
72.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-10
Pulmonx Corp Q3 FY2020 Earnings Call
Revenue
$10.61M
▲ 16.6% YoY
Diluted EPS
$-1.37
Gross margin
70.3%
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–25 of 25 earnings calls
Key facts CIK 1127537 CUSIP 745848101 13F (30d) 105 filings 102 filers Visit website

Report a Problem

Category
Description
Email (optional, for follow-up)